- Home
- EBS vs NAKA Comparison
EBS vs NAKA Comparison
Compare EBS & NAKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- NAKA
- Stock Information
- Founded
- EBS 1998
- NAKA 2019
- Country
- EBS United States
- NAKA United States
- Employees
- EBS N/A
- NAKA N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- NAKA
- Sector
- EBS Health Care
- NAKA
- Exchange
- EBS Nasdaq
- NAKA Nasdaq
- Market Cap
- EBS 423.6M
- NAKA 347.4M
- IPO Year
- EBS 2006
- NAKA 2024
- Fundamental
- Price
- EBS $10.48
- NAKA $0.89
- Analyst Decision
- EBS Strong Buy
- NAKA Strong Buy
- Analyst Count
- EBS 2
- NAKA 2
- Target Price
- EBS $13.50
- NAKA $5.00
- AVG Volume (30 Days)
- EBS 1.4M
- NAKA 33.7M
- Earning Date
- EBS 10-29-2025
- NAKA 11-05-2025
- Dividend Yield
- EBS N/A
- NAKA N/A
- EPS Growth
- EBS N/A
- NAKA N/A
- EPS
- EBS 1.35
- NAKA N/A
- Revenue
- EBS $788,900,000.00
- NAKA $2,239,936.00
- Revenue This Year
- EBS N/A
- NAKA N/A
- Revenue Next Year
- EBS $19.24
- NAKA $2,755.19
- P/E Ratio
- EBS $7.77
- NAKA N/A
- Revenue Growth
- EBS N/A
- NAKA N/A
- 52 Week Low
- EBS $4.02
- NAKA $0.65
- 52 Week High
- EBS $13.41
- NAKA $34.77
- Technical
- Relative Strength Index (RSI)
- EBS 54.80
- NAKA 35.46
- Support Level
- EBS $9.21
- NAKA $0.84
- Resistance Level
- EBS $13.41
- NAKA $0.98
- Average True Range (ATR)
- EBS 0.82
- NAKA 0.10
- MACD
- EBS 0.17
- NAKA 0.20
- Stochastic Oscillator
- EBS 32.84
- NAKA 55.70
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About NAKA Kindly MD Inc. Common Stock
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.